Navigation

Innovation showcases

Below are just some examples of successful ATN ventures that have made significant contributions to the local community and our society at large. More case studies can also be found in our 50 Solutions that Count publication. 

Curtin – iCetana

Curtin University spin-off company iCetana received patent approval from the United States Patent and Trademark Office in 2014, and was a winner of the “Broadband Innovation Award” at the 2010 Tech 23 Event, the WA Innovator of the Year Award in 2011, and Milestone System’s “Best Solution Partner” in 2013.

It's innovative surveillance software reports only significant rare or infrequent motion events in video surveillance. It's video analytics solution means that less than one percent of video surveillance footage that might contain events such as loitering, anti-social behaviour and traffic violations needs to be viewed by CCTV surveillance operators. Read more...

RMIT – Anti-Turbulance Technology

Inspired by nature’s own anti-turbulence devices – feathers – RMIT University researchers have developed an innovative system that could spell the end of turbulence on flights. Researchers from RMIT’s Unmanned Aircraft Systems Research Team have lodged a provisional patent on the system, which mimics the way feathers help birds detect disturbances in the air. Read more...

UniSA Ventures – Codha Wireless

University of South Australia spin-off company Cohda Wireless is a 'car-to-car' communications technology company that allows cars to ‘talk’ to each other and reduce or eliminate crashes through data transmission that provides drivers with an audio or visual alert in the threat of an accident. It is estimated by the US Department of Transport that these car-to-car technologies may address up to 82 per cent of crash scenarios. Learn more...

UTS - Auspherix

UTS ithree institute disease research has led to the formation of a new company, Auspherix Pty Ltd, that will explore the commercial potential of drugs to fight infections caused by bacteria that have become resistant to currently available antibiotics.

The company has received a $1m investment from Australia’s Medical Research Commercialisation Fund (MRCF) and will be used to explore ways to improve the antibiotic activity of drugs that have been identified through a screening program undertaken at the ithree institute and to establish initial safety and efficacy data in in vivo models. Learn more...